biotech stock review, fluticare

Innovus (INNV): Twenty-Eight Drugs in Five Years. (San Diego Reader)

(Originally published 4/25/2018) “I am very steady. I like to work slowly, but surely, to get to my goal.” Thus speaks Bassam Damaj, president and...
biotech stock review, innovus

Adding Innovus Pharma (INNV) $2.50 to Watch List.

Fast Growing eCommerce and Direct to Consumer Pharma Company Announces 1st Foray into CBD and 2nd Major Off-Patent Blockbuster Drug to its lineup. We're adding...
biotech stock review, zestra

Innovus Pharma (INNV) Partners With Lavasta’s 150 Member Sales Force for Female Sexual Arousal!

Dubai based Lavasta is a pharmaceutical marketing company that offers niched unique medications based on the latest scientific innovations that defy current therapeutic conventions....
Internet Stock Review

MySizeID (MYSZ) Widget now on Shopify’s (SHOP) Site Provides Personalized, Efficient Online Shopping Experience.

My Size $MYSZ Announces General Availability of MySizeID™ Mobile Measurement Technology on Leading E-Commerce Platform. (Older but very interesting news as we study more.) Shopify...

Can MySize (MYSZ) Solve the Massive eCommerce ‘Returns’ Problem?

The mounting cost of returns is a growing and scary problem for many retailers that simply cannot go unchecked much longer. The Ticking Time...

Internet Stock Review Initiates Coverage On HealthLynked Corp. (HLYK) $0.23.

NAPLES, Fla., Oct. 04, 2017 (GLOBE NEWSWIRE) -- HealthLynked Corp. (HLYK) today announced it has retained Institutional Analyst Inc., to provide coverage to investors...
zestra, biotech stock review

Innovus (INNV) Zestra® Female Sexual Arousal Oils Featured in NY Times.

Erin Drought, a 28-year-old information technology consultant in Edmonton, Alberta, who says her sex drive evaporated after she began taking medicine for bipolar disorder,...
Biotech Stock Review

Christopher E. Rivera Appointed to the Council of Washington Biotechnology & Biomedical Association

WASHINGTON, DC and SEATTLE, WA – (June 27, 2011) – Today the Washington Biotechnology & Biomedical Association (WBBA) and the Biotechnology Industry Organization (BIO)...

Latest article

Jeffrey Gundlach: Reckoning is Coming.

Jeffrey Edward Gundlach is a businessman, fund manager, and philanthropist. He is the founder of DoubleLine Capital, an investment firm. On 11 November 2020, Gundlach remarked in an interview with...

Who’s the Next Eric Sprott?

Eric Sprott, on Who is the Next Eric Sprott! To say Eric Sprott has left a legendary mark on the world of mining investment would...

Perpetua (PPTA) Raises $300 Million.

Not a bad day in Idaho. $300 million banked! We look at the dip as a buying opportunity, as does John Paulson & Co.,...